RxAll is an AI-hyperspectral Platform for Authenticating Drugs.
Our platform uses a proprietary molecular sensor device with a cloud-based IP-protected AI algorithm and database of spectral signatures of drugs- both prescription and recreational- to carry out non-destructive drug authentication.
We work with drug regulators and other stakeholders to reduce branded drug counterfeiting and ensure that patients receive high quality authenticated drugs. Pharma manufacturers increase sales and patients have better access to high quality drugs.
We are expanding our business in Southeast Asia, Africa and the Americas. We are currently operational in Canada, China, Myanmar, Kenya, Uganda, Ghana and Nigeria.
Users will find RxAll’s technology unique as it aims to assure the quality of drugs delivered to patients across the world.